The rheumatoid arthritis drug auranofin lowers leptin levels and exerts antidiabetic effects in obese mice
Aaron R. Cox, Peter M. Masschelin, Pradip Saha, Jessica B. Felix, Robert Sharp, Zeqin Lian, Yan Xia, Natasha Chernis, David Bader, Kang Ho Kim, Xin Li, Jun Yoshino, Xin Li, Gang Li, Zheng Sun, Huaizhu Wu, Cristian Coarfa, David D. Moore, Samuel Klein, Kai Sun, Sean M. Hartig
Topics & Concepts
AuranofinHyperinsulinemiaLeptinRheumatoid arthritisMedicineInternal medicineEndocrinologyInflammationInsulin resistanceAdipose tissueType 2 Diabetes MellitusType 2 diabetesInsulinLeptin receptorDiabetes mellitusArthritisPharmacologyObesityRegulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism